Company / Current Assets per Share
Editas Medicine, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.98
FY2025
5-year range
$1.98 / $8.11
FY2021-FY2025
Trend
-44.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 4 consecutive years, from $8.11 in FY2021 to $1.98 in FY2025.
Based on SEC 10-K filings.
1.98 in FY2025 with a 5-year CAGR of -23.8%.
Declined from $4.95 to $1.98 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -27.6%
- 5-Year CAGR
- -23.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Editas Medicine, Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2025, current assets per share decreased 44.0% year-over-year.
- Peak current assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.98 | -44.0% |
| FY2024 | $3.54 | -28.5% |
| FY2023 | $4.95 | -5.0% |
| FY2022 | $5.21 | -35.7% |
| FY2021 | $8.11 | +5.2% |
| FY2020 | $7.71 | -19.0% |
| FY2019 | $9.51 | +13.0% |
| FY2018 | $8.42 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026